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THYROID NODULARITY - TRUE EPIDEMIC 
OR IMPROVED DIAGNOSTICS 
Josip StaniCic, Marin Prpic, Tomislav Jukic, Marta Boric and Zvonko Kusic 
University Department of Oncology and Nuclear Medicine, Sestre milosrdnice University Hospital, 
Zagreb, Croatia 
SUMMARY - The incidence of thyroid nodules has been rising steadily during the last 30 
years, since the introduction of new diagnostic methods such as ultrasonography and computerized 
tomography, thus posing a real challenge in determining the best approach strategy for treatment of 
this new 'epidemic'. We analyzed and compared data from several studies showing the prevalence of 
thyroid nodules on autopsy, palpation and ultrasonography to be 13%-60%, 0.5%-6.5% and 13.4%-
46%, respectively. This demonstrates that thyroid ultrasonography is a very sensitive and accurate 
diagnostic tool the use of which, however, entails an increased number of incidentally discovered 
thyroid nodules without clinical significance. Therefore, ultrasonography of the thyroid should not 
be performed without clinical indication determined by thyroid specialist. 
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Introduction 
Thyroid nodule can be defined as an area within 
the thyroid gland that is distinct from the surrounding 
thyroid parenchyma on palpation and/or ultrasonog-
raphy!. It usually is not caused by a single disease but 
is a clinical manifestation of many different thyroid 
diseases. Thyroid nodules are the most common thy-
roid disease. The prevalence of clinically detectable 
thyroid nodules is around 3% in the general popula-
tion, while the incidence is 0.1%2 Thyroid nodules are 
usually benign3.'. However, the risk of thyroid cancer 
in a nodule is around 5%5 and cannot be considered 
negligible. 
The factors that influence the incidence of thyroid 
nodules include age and sex, iodine intake and expo-
sure to radiation. Thyroid nodules are up to five times 
Correspondence to: Josip StaniCit, MD, University Department of 
Oncology and Nuclear Medicine, Sestre milosrdnice University 
Hospital, Vinogradska c. 29, HR-10000 Zagreb, Croatia 
E-mail: 
Received July 17, 2009, accepted September 15, 2009 
more frequent in women than in men. I t is also known 
that the prevalence of thyroid nodules increases with 
age'·6-9 Even small differences in the levels of iodine 
intake can have profound effect on the occurrence of 
thyroid abnormalities. It has been proven that nodular 
thyroid disease, especially multinodular toxic goiter, is 
more frequent in iodine deficient regions10 , pointing 
to the level of dietary iodine as an important etiologic 
factor in the development of thyroid autonomy. In ad-
dition, a significant linear radiation dose response has 
been reported for thyroid nodules including malignant 
tumors and benign nodules11 . The sources of ionizing 
radiation may be atomic bomb, nuclear accidents, ra-
diotherapy, etc. Young age at exposure is a primary 
risk for cancer after radiation exposure because the 
thyroid gland of children is especially vulnerable to 
the carcinogenic action of ionizing radiation. 
Clinical evaluation of patients with thyroid nod-
ules includes palpation, serum thyroid-stimulating 
hormone (TSH), thyroid ultrasonography (US), thy-
roid scintigraphy, and fine needle aspiration biopsy 
(FNA), which is currently considered the most accu-
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Table 1. Prevalence of thyroid nodules on autopsy 
Country Prevalence of nodules Author(s) 
USA 13% (soldiers aged 18-39) Oertel and Klinck, 196516 
Hungary (Szolnok, Budapest) 
27.1% Iodine sufficiency 
Kovacs et al., 200517 
44.6% Iodine deficiency 
USA 50.5% 
Belarus 60% 
rate diagnostic method to differentiate benign from 
malignant thyroid nodules1,12-1 5. Since the introduction 
of new diagnostic methods such as US and computer-
ized tomography (CT), there has been a steady rise 
in the incidence of thyroid nodules in the past thirty 
years. This rising tendency is the result of incidental 
detection of nodules smaller than 1 cm, detection of 
clinically non-significant nodules on routine neck US 
or non-thyroid diagnostic tests like US of parathy-
roid glands, cervical lymph nodes or salivary glands, 
Doppler assessment of carotid arteries, and neck or 
chest CT or magnetic resonance imaging (MRI) and 
positron emission tomography (PET). These nodules, 
appropriately named incidentalomas, present a real 
challenge to all thyroid specialists in determining the 
best approach strategy for their treatment. 
Prevalence of Thyroid Nodules - Autopsy Data 
The 'real' prevalence of thyroid nodules can be ac-
curately verified only with data obtained on autopsy. 
Relevant studies assessing thyroid nodularity on au-
topsy were conducted in the past and concluded that 
20%-60% of the general population with no previous-
ly recorded thyroid abnormalities had nodular thyroid 
disease (Table 1). The prevalence depended on age, sex 
and dietary iodine, as stated above. 
Mortensen et al., 1955 
(Mayo Clinic)'8 
Furmanchuk et al., 199319 
Methods of Detection 
Thyroid nodules are usually detected on neck pal-
pation or US. Thyroid palpation is still considered a 
routine method of nodular thyroid disease detection. 
However, even the most experienced physician can-
not detect thyroid nodules of less than 1 cm in di-
ameter, which obviously limits the method reliabil-
ity. Historically, until some thirty years ago, thyroid 
palpation was a standard method of evaluation, but 
was supplanted by US as a significantly more sensi-
tive technique. In the studies we reviewed, the preva-
lence of nodular thyroid disease varied between 0.5% 
and 6% (Table 2); however, not all of these studies 
were conducted on randomized populations, so lower 
and higher values were expected in younger and older 
populations, respectively. 
Ultrasonography was introduced as a method of 
thyroid imaging in 1967 by Fujimoto", having dra-
matically changed diagnostic work-up and manage-
ment of patients with thyroid disorders, in the last 
20 years in particular. It is a reliable and noninvasive 
method to detect thyroid lesions and to distinguish 
solid from cystic lesions25. Currently, US can detect 
thyroid lesions as small as 2 mm, which makes it the 
most accurate imaging technique for the detection of 
thyroid nodules. This procedure is mandatory when a 
Table 2. Prevalence ofpalpable thyroid nodules 
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Country 





Prevalence of nodules 
0.46% (schoolchildren) 




6.5% (middle age women) 
Author(s) 
Rallison et al., 1991 20 
Tunbridge et al., 19772 
Vander et al., 196821 
Belfiore et al., 198722 
Christensen et al., 198423 
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Prevalence of nodules 
13.4% 
17% (age >15) 
19.7% 
21.3% 
23.4% (age 18-65) 
31.3% (age 41-71) 
33.1% 
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Author(s) 
Carol!, 198226 
Aghini-Lombardi et al., 199929 
Miki et aI., 199327 
Brander et al., 1991 28 
Reiners et al., 20047 
Knudsen et al., 200030 
Bartolotta et al., 200631 
USA (San Francisco) 
USA 
40% (patients with hyperparathyroidism) 
46% 
Stark et al., 198332 
Horlocker et al.,1985 6 
Most of these countries were iodine sufficient at the time of the respective study, and only Italy and Germany were mildly iodine deficient. 
nodule is discovered on palpation. US is also used as a 
guide to FNA biopsy. 
In the past 25 years, a number of studies assessing 
the prevalence of thyroid nodules have been conduct-
ed in various countries and in various populations a11 
over the world. In these studies, the prevalence ranged 
from 13.4% to 46% (Table 3). Probably the most ex-
tensive prospective study was performed by Reiners 
et aI., which included almost 100,000 employees of 
various companies throughout Germany and yielded 
very comprehensive data on thyroid nodule prevalence 
according to age and sex7. 
Discussion 
Data collected from these studies show great dis-
parity between the prevalence of palpable thyroid 
nodules and real prevalence found on autopsy. On the 
other hand, the prevalence of nodules discovered on 
US was in line with autopsy data, demonstrating that 
US is a very sensitive and accurate diagnostic tool for 
thyroid gland examination, whereas palpation is lim-
ited by the experience of the examiner and difficult 
detection of small nodules. However, the widespread 
use of US and other new diagnostic methods entails 
an increase in the number of incidentally discovered 
nodules without clinical significance, posing a prob-
lem of how to manage these new 'patients'. Fortunate-
ly, the majority of thyroid nodules are benign and only 
a small percentage require surgical treatment. What is 
more important, most benign thyroid nodules are as-
ymptomatic, nontoxic and slow-growing and require 
only simple follow-up33 
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However, as mentioned above, around 5% of thy-
roid nodules are or will become malignant. Clinically 
apparent thyroid cancer is a relatively uncommon ma-
lignancy with a prevalence of 0.1% and even lower 
mortality34,35, but its incidence has been increasing 
steadily over the past 30 years9 This phenomenon can 
also be mainly ascribed to the introduction of new 
diagnostic methods, US in particular, since the pool 
of so-called 'occult thyroid cancers' is substantial, i.e. 
5% to 36% in autopsy studies in various countries36 -38 . 
These data demonstrate that thyroid cancer is actu-
ally much more common than suggested by clinical 
studies, and that the majority of clinically unapparent 
cancers would remain 'silent' throughout the patient's 
life l9 
Considering these facts, what should be our ap-
proach to thyroid nodules and their potential malig-
nant transformation? Current guidelines for the man-
agement of thyroid nodules issued by the American 
and European thyroid associations clearly state that 
US screening of the general population for thyroid 
nodules is not recommended. These guidelines also 
recommend to perform US-guided FNA on all pal-
pable and non-palpable thyroid nodules with a cut-off 
value of 1-1.5 cml.12-14.40.41 FNA of nodules smaller 
than this cut-off value is recommended only in nodules 
with suspect US characteristics (hypoechoic, solid, ir-
regular margins, intranodular vascular pattern, micro-
calcifications). In case of multinodular goiter, FNA is 
recommended in dominant nodules and nodules with 
previously mentioned suspect characteristics. This ap-
proach could, however, further increase the detection 
rate of thyroid cancer by detecting small, clinically 
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unapparent occult thyroid cancers2?, while the benefit 
for these patients would be dubious. 
Conclusion 
Thyroid nodules are discovered at an ever increas-
ing rate since the introduction of modern diagnostic 
tools like CT, MRI, PET scans and US in particular, 
which is becoming an extension of physical examina-
tion of the thyroid. Since the pool of non-palpable, 
clinically non-significant thyroid nodules is huge, this 
increase could actually be expected and there has been 
no evidence of true increase of thyroid nodularity. The 
risk of malignancy should not be ignored since an es-
timated 5% of all nodules are malignant; however, the 
majority of these malignancies have little biological 
significance. Therefore, US of the thyroid should not 
be performed without clinical indication determined 
by thyroid specialist. 
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Saietak 
CVOROVI STITNE ZLlJEZDE - STVARNA EPIDEMIJA ILl POBOLJSANA DIJAGNOSTIKA 
J StaniCic, M. Prpic, T Jukic, M. Boriii Z. Kusic 
Incidencija cvorova stitne ilijezde u stalnom je porastu posljednjih 30 godina, od uvodenja novih dijagnostickih me-
toda poput ultrazvuka i kompjutorizirane tomografije, sto predstavlja pravi izazov pri odredivanju najboljeg pristupa u 
lijecenju ove nove 'epidemije'. Analizirali smo i usporedili podatke iz nekoliko istraiivanja koja navode ucestalost cvorova 
stitne ilijezde utvrdenih na autopsiji, palpacijom i ultrazvukom od 13%-60%, 0,5%-6,5%, odnosno 13,4%-46%. To poka-
zuje kako je ultrazvuk vrlo osjetljiva i tocna dijagnostiCka metoda, medutim, njegova primjena dovodi do sve veceg broja 
slueajno otkrivenih, klinicki neznaeajnih cvorova stitnjace. Stoga ultrazvuk stitnjace ne treba primjenjivati bez kliniCke 
indikacije koju je postavio specijalist za stitnu ilijezdu. 
Kljucne rijeci: ever ftitne iliJezde - anamneza; evor ftitne iliJezde - patologija; evor ftitne zliJezde - terapiJa; ever ftitne 
iliJezde - ultrazvuk; Tomograjija, kompjutorizirani rtg 
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